Concurrent OPA1 mutation and chromosome 3q deletion leading to Behr syndrome: a case report

BMC Pediatr. 2020 Sep 3;20(1):420. doi: 10.1186/s12887-020-02309-0.

Abstract

Background: Optic atrophy 1 (OPA1) gene mutations are associated with dominantly inherited optic neuropathy resulting in a progressive loss of visual acuity. Compound heterozygous or homozygous variants that lead to severe phenotypes, including Behr syndrome, have been reported rarely.

Case presentation: Here, we present a 14-month-old boy with early onset optic atrophy, congenital cataracts, neuromuscular disorders, mental retardation, and developmental delay. Combined genetic testing, including whole exome sequencing (WES) and chromosomal microarray analysis, revealed a concurrent OPA1 variant (c.2189 T > C p.Leu730Ser) and de novo chromosome 3q deletion as pathogenic variants leading to the severe phenotype.

Conclusions: Our case is the first reporting a novel missense OPA1 variant co-occurring with a chromosomal microdeletion leading to a severe phenotype reminiscent of Behr syndrome. This expands the mutation spectrum of OPA1 and inheritance patterns of this disease.

Keywords: Behr syndrome; Case report; Microdeletion; OPA1; Optic atrophy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ataxia
  • Chromosomes
  • GTP Phosphohydrolases / genetics
  • Hearing Loss
  • Humans
  • Infant
  • Intellectual Disability* / diagnosis
  • Intellectual Disability* / genetics
  • Male
  • Mutation
  • Optic Atrophy* / congenital
  • Optic Atrophy* / genetics
  • Pedigree
  • Spasm

Substances

  • GTP Phosphohydrolases
  • OPA1 protein, human

Supplementary concepts

  • Behr syndrome